Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants.
about
Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritisGenome-Wide Association Study in Immunocompetent Patients with Delayed Hypersensitivity to Sulfonamide AntimicrobialsIdiosyncratic toxicity associated with potentiated sulfonamides in the dog.Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System.Diagnosis of allergic reactions to sulfonamides.Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis.Mechanisms in cutaneous drug hypersensitivity reactions.Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.Novel treatments for drug-induced toxic epidermal necrolysis (Lyell's syndrome).Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome.HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese.Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity.Hypersensitivity reactions due to black henna tattoos and their components: are the clinical pictures related to the immune pathomechanism?Toxic epidermal necrolysis following morbilli-parotitis-rubella vaccination.Lamotrigine-induced toxic epidermal necrolysis treated with intravenous cyclosporin: a discussion of pathogenesis and immunosuppressive management.Don't live in a town where there are no doctors: toxic epidermal necrolysis initially misdiagnosed as oral thrush.Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome.Toxic epidermal necrolysis in a patient infected with human immunodeficiency virus-2.RNA expression profiling in sulfamethoxazole-treated patients with a range of in vitro lymphocyte cytotoxicity phenotypes.
P2860
Q24804632-99741DC2-E604-472E-8F9F-D8301A616842Q28550088-C6119727-1595-453C-BB7D-103BB87CC72DQ33361195-9A6E85DD-4FCF-4193-AA1C-46EA4555EE1DQ33838853-29C77923-DCC4-4539-8B7F-F8B892DC0854Q33874332-D867BAE8-FCE5-4BA5-B1C8-42047CB6A118Q34830063-8DF1E254-5002-4EDA-8B9C-40F56640AB6CQ35177407-9A8A7749-F0DE-4852-AD81-F77592DD6D31Q35749162-43FD34BA-213C-42C8-9D99-A69BE6C0A947Q36043283-C5555E4C-77F3-4F5F-A34B-5F88F4328ED4Q36494105-123CC3B4-8CCB-4933-989D-C85937527E63Q36508660-5F40F237-3769-4406-ABFB-1C5A572F2AEDQ36747900-E77B0297-6FE1-45D6-9CD1-5E1B37D1CC8BQ39236027-EBFD5B6E-707D-4AB5-BB25-1154124C6987Q40630063-1EB4DC55-B65B-44B8-857D-C0347B1D6434Q41265631-22824ABF-046E-4E67-A412-562CCB014565Q42582535-E1328BB2-9637-448F-A6A5-2881D3F033CFQ43644050-E2A21A8A-D184-43CC-ADE9-3C3F984B8E63Q45732901-6D062AC2-77A6-4890-ABC2-529389AF90CCQ55068342-9B146EB9-A202-41EA-AF9F-DE99246C10ED
P2860
Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Metabolic predisposition to cu ...... fonamides and anticonvulsants.
@en
Metabolic predisposition to cu ...... fonamides and anticonvulsants.
@nl
type
label
Metabolic predisposition to cu ...... fonamides and anticonvulsants.
@en
Metabolic predisposition to cu ...... fonamides and anticonvulsants.
@nl
prefLabel
Metabolic predisposition to cu ...... fonamides and anticonvulsants.
@en
Metabolic predisposition to cu ...... fonamides and anticonvulsants.
@nl
P2093
P1433
P1476
Metabolic predisposition to cu ...... fonamides and anticonvulsants.
@en
P2093
P304
P356
10.1001/ARCHDERM.131.5.544
P577
1995-05-01T00:00:00Z